Clinical ink announced the appointment of Dr. Nicholas Alp as Chief Medical Officer will lead the creation of innovative solutions and commercial strategies for clinical trial technology based on his experience as an interventional cardiologist and clinical trialist.The post Clinical ink Appoints Dr. Nicholas Alp, MD PhD as Chief Medical Officer appeared first on Clinical ink.
Clinical Ink is a Pennsylvania-based clinical trial platform that provides solutions such as data management and patient engagement for the healthcare sector.